– CNBC
SVB Leerink Maintains Market Perform on Oak Street Health, Raises Price Target to $39
SVB Leerink analyst Whit Mayo maintains Oak Street Health (NYSE:OSH) with a Market Perform and raises the price target from $33 to $39.
CNBC Halftime Report Final Trades: Caterpillar, CVS Health, Apple & Microsoft
– CNBC
Related Posts
Barclays Downgrades Hyatt Hotels to Equal-Weight, Lowers Price Target to $125
Barclays analyst Brandt Montour downgrades Hyatt Hotels (NYSE:H) from Overweight to Equal-Weight and lowers the price target from $130 to $125.
Analysts Highlight Target’s Market Share Struggles And Increased Competition: Details
BMO Capital's Kelly Bania reiterates Market Perform for Target but lowers the price target from $170 to $155. Despite 1Q results meeting expectations, concerns arise over continued gross margin upside, share losses in food and consumables, and competition from Amazon and Walmart.
Oppenheimer Maintains Outperform on Prometheus Biosciences, Raises Price Target to $125
Oppenheimer analyst Jeff Jones maintains Prometheus Biosciences (NASDAQ:RXDX) with a Outperform and raises the price target from $61 to $125.